ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Oldngrumpy
|
83 |
15K |
5 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
83
|
15K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Oldngrumpy
|
83 |
15K |
12 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
83
|
15K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Oldngrumpy
|
83 |
15K |
10 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
83
|
15K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing
|
|
Oldngrumpy
|
125 |
24K |
9 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
125
|
24K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing
|
|
Oldngrumpy
|
125 |
24K |
3 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
125
|
24K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
PHARMAUST 2023 AGM.
|
|
Oldngrumpy
|
15 |
3.1K |
10 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
15
|
3.1K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
PHARMAUST 2023 AGM.
|
|
Oldngrumpy
|
15 |
3.1K |
7 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
15
|
3.1K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
Oldngrumpy
|
380 |
83K |
12 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
380
|
83K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
Oldngrumpy
|
380 |
83K |
11 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
380
|
83K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Trial Update
|
|
Oldngrumpy
|
126 |
28K |
11 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
126
|
28K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
Oldngrumpy
|
380 |
83K |
9 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
380
|
83K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Trial Update
|
|
Oldngrumpy
|
126 |
28K |
16 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
126
|
28K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem enters voluntary liquidation
|
|
Oldngrumpy
|
218 |
50K |
9 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
218
|
50K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem enters voluntary liquidation
|
|
Oldngrumpy
|
218 |
50K |
9 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
218
|
50K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem enters voluntary liquidation
|
|
Oldngrumpy
|
218 |
50K |
4 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
218
|
50K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem enters voluntary liquidation
|
|
Oldngrumpy
|
218 |
50K |
11 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
218
|
50K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem enters voluntary liquidation
|
|
Oldngrumpy
|
218 |
50K |
7 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
218
|
50K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
Oldngrumpy
|
396 |
82K |
7 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
396
|
82K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Results show MPL suppresses biomarkers associated with MND
|
|
Oldngrumpy
|
200 |
41K |
8 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
200
|
41K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Louie the Beagle surpasses one year on MPL
|
|
Oldngrumpy
|
37 |
7.5K |
6 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
37
|
7.5K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
Oldngrumpy
|
396 |
82K |
13 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
396
|
82K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
Oldngrumpy
|
396 |
82K |
5 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
396
|
82K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
Oldngrumpy
|
396 |
82K |
10 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
396
|
82K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
Oldngrumpy
|
396 |
82K |
7 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
396
|
82K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
Oldngrumpy
|
396 |
82K |
10 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
396
|
82K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Catalysts Before October to Enact The Options
|
|
Oldngrumpy
|
89 |
21K |
2 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
89
|
21K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Commencement of Cohort 3 in Phase 1/2 MND Trial
|
|
Oldngrumpy
|
151 |
31K |
7 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
151
|
31K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Trial Update
|
|
Oldngrumpy
|
205 |
43K |
6 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
205
|
43K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Trial Update
|
|
Oldngrumpy
|
205 |
43K |
6 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
205
|
43K
|
6
|
|
Charts
|
PAA Biotech |
Re:
GENERAL MEETING VOTING CORRECTLY
|
|
Oldngrumpy
|
33 |
7.3K |
6 |
31/05/23 |
31/05/23 |
Charts
|
33
|
7.3K
|
6
|
|
Charts
|
PAA Biotech |
Re:
GENERAL MEETING VOTING CORRECTLY
|
|
Oldngrumpy
|
33 |
7.3K |
6 |
31/05/23 |
31/05/23 |
Charts
|
33
|
7.3K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Motor Neurone Disease Clinical Trial Update
|
|
Oldngrumpy
|
147 |
34K |
16 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
147
|
34K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Oldngrumpy
|
88 |
16K |
8 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
88
|
16K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Oldngrumpy
|
88 |
16K |
4 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
88
|
16K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Oldngrumpy
|
88 |
16K |
8 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
88
|
16K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Oldngrumpy
|
88 |
16K |
2 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
88
|
16K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Oldngrumpy
|
88 |
16K |
5 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
88
|
16K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Oldngrumpy
|
88 |
16K |
3 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
88
|
16K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Oldngrumpy
|
88 |
16K |
4 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
88
|
16K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Oldngrumpy
|
88 |
16K |
4 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
88
|
16K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Oldngrumpy
|
88 |
16K |
3 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
88
|
16K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Oldngrumpy
|
88 |
16K |
9 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
88
|
16K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Oldngrumpy
|
88 |
16K |
7 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
88
|
16K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Oldngrumpy
|
88 |
16K |
2 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
88
|
16K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Oldngrumpy
|
88 |
16K |
11 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
88
|
16K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
South Korean Biotech 2023
|
|
Oldngrumpy
|
46 |
9.4K |
8 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
46
|
9.4K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
South Korean Biotech 2023
|
|
Oldngrumpy
|
46 |
9.4K |
5 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
46
|
9.4K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Price manipulation
|
|
Oldngrumpy
|
33 |
6.6K |
9 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
33
|
6.6K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Progress update on Phase 1/2 MND interim analysis
|
|
Oldngrumpy
|
65 |
16K |
12 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
65
|
16K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Progress update on Phase 1/2 MND interim analysis
|
|
Oldngrumpy
|
65 |
16K |
5 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
65
|
16K
|
5
|
|